We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Accelrys, Inc. (MM) | NASDAQ:ACCL | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 12.51 | 0 | 01:00:00 |
From Jun 2019 to Jun 2024
The French software company said the Committee on Foreign Investment in the United States is required to complete its investigation of the acquisition until May 8 but could complete it earlier than that.
"Dassault Systemes continues to believe the acquisition of Accelrys by Dassault Systemes does not raise national security concerns," the company said in a statement.
The tender offer is extended only until April 22 because of an agreement with Accelrys that the offer can only be extended in 10 business day blocks.
Dassault Systemes offered in late January to pay $12.50 for each Accelrys share, valuing the company at $750 million. Accelrys shares were traded at $9.72 before the offer.
Dassault Systemes said except for the extension, all other terms of the offer remain unchanged.
San Diego-based Accelrys makes biotech, petrochemical and pharmaceutical industrial software for companies like Sanofi, Pfizer, Royal Dutch Shell, Unilever and L'Oreal.
Write to Ruth Bender at ruth.bender@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Accelrys, Inc. (MM) Chart |
1 Month Accelrys, Inc. (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
